Anti-infective agents and uses thereof

US8501238B2 · kind B2 · utility

Assignee

• Abb Vie Inc. · US

Inventors

• Charles A. Flentge · Salem, US
• Douglas K. Hutchinson · Antioch, US
• David A. Betebenner · Lawrenceville, US
• David A. DeGoey · Salem, US
• Pamela L. Donner · Mundelein, US
• Warren M. Kati · Gurnee, US
• Allan C. Krueger · Gurnee, US
• Dachun Liu · Vernon Hills, US
• Yaya Liu · Buffalo Grove, US
• Kenton L. Longenecker · Grayslake, US
• Clarence J. Maring · Libertyville, US
• Christopher E. Motter · Oak Creek, US
• John K. Pratt · Kenosha, US
• John T. Randolph · Libertyville, US
• Todd W. Rockway · Gurnee, US
• Kent D. Stewart · Gurnee, US
• Rolf Wagner · Antioch, US
• Shuang Chen · Gurnee, US
• Yi Gao · Vernon Hills, US
• Xiaochun Lou · Long Grove, US
• Geoff G. Zhang · Vernon Hills, US

Key dates

• Filing date: Apr 20, 2012
• Grant date: Aug 6, 2013
• Expiry date: Apr 20, 2032

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.